Is AMOQ DISPERSIBLE TABLETS registered in Ghana?

AMOQ DISPERSIBLE TABLETS is recorded with registration status “Valid” in Ghana, registration number FDA/SD.265-070719, based on FDA Ghana data.

Who manufactures AMOQ DISPERSIBLE TABLETS?

AMOQ DISPERSIBLE TABLETS is manufactured by Ajanta Pharma Ltd.

What is the active ingredient in AMOQ DISPERSIBLE TABLETS?

AMOQ DISPERSIBLE TABLETS contains TOFACITIRIB, dosage form TOFACITIRIB.

Valid Ghana · FDA Ghana

AMOQ DISPERSIBLE TABLETS

TOFACITIRIB

FDA/SD.265-070719 TOFACITIRIB

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

FDA/SD.265-070719

Registration date

2026-07-30

Expiry date

2031-08-01

Status

Valid

Active ingredient

TOFACITIRIB

Dosage form

TOFACITIRIB

Strength

Pack size

Therapeutic class

Manufacturer / MAH

Ajanta Pharma Ltd

Applicant / LTR

GOKALS LTD

Country of origin

INDIA

Source: Food and Drugs Authority · fetched 2026-09-01 04:00:37 · updated 2026-10-20 04:00:14

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.